Skip to content

About / Media Center

Trinity News

Filter by Type:
August 24, 2025

AI is Ushering in a New Era for Life Sciences, According to Top Life Sciences Firm

Trinity Life Sciences’ Head of Digital & AI Solutions, Jonathan Jenkins, spoke with Grit Daily about how artificial intelligence is transforming the life sciences industry by shifting it from static insights to dynamic, continuous intelligence.
Read More
May 7, 2025

Health equity can be a competitive advantage: What pharma leaders need to know

Trinity Life Sciences’ Managing Director and Head of Value Center of Excellence, Mary Fletcher-Louis, spoke with pharmaphorum about how health equity can be a competitive advantage in HTA decisions.
Read More
April 3, 2025

NICE leads global shift: How health equity is influencing drug approvals

Trinity Life Sciences’ Managing Director and Head of Value Center of Excellence, Mary Fletcher-Louis, spoke with Access Insider about how the UK’s National Institute for Health and Care Excellence (NICE) is spearheading a global shift in pharmaceutical decision-making by incorporating health...
Read More
March 12, 2025

Argenx’s Vyvgart tops Trinity’s latest launch success analysis, beating out several Big Pharma debuts

The Trinity Annual Drug Index was featured in an article by Fierce Pharma: Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, according to the latest edition of Trinity Life...
Read More
February 19, 2025

MM+M unveils the 2025 Pinnacle Award honorees

Leslie Orne was named as one the MM+M 2025 Pinnacle Award honorees. Read the article to learn more.
Read More
February 13, 2025

Salesforce or Veeva: How drugmakers can navigate the upcoming CRM split

Nancy Phelan, Senior Vice President and Head of Customer Engagement, was featured in an article in PharmaVoice discussing the upcoming CRM split: “A lot of leaders are starting to realize this is a much bigger decision, and they need to think...
Read More
February 12, 2025

Changing Political Winds and the IRA: Q&A with Monica Martin de Bustamante

Trinity’s Monica Martin de Bustamante, Senior Partner & Head of Advisory, spoke with Pharmaceutical Executive about the Inflation Reduction Act and how companies are attempting to strategize around the uncertainty of upcoming pricing negotiations. Read the article to learn more.
Read More
January 31, 2025

Pharma sales reps juggle digital tools, data and AI, but physician relationships are more important than ever

“Now is the right time for organizations to step back and say ‘what do we need organizationally to make the very valuable in-person engagement, whether it’s from a rep, medical science liaison, nurse educator or whomever, how do we set them...
Read More
January 10, 2025

Scrip Asks… What Does 2025 Hold For Biopharma? Part 1: The State Of The Biopharma Industry

Trinity Life Sciences’ President and CEO, Leslie Orne, was quoted in an article by Scrip on the state of the biopharma industry in 2025.
Read More
December 18, 2024

AZ and Pfizer top list of best digital pharma marketers, but other brands closing in: study

Trinity Life Sciences’ Jerry Luciano and Tim McLaughlin were featured in an article by Marketing & Pharma titled, “AZ and Pfizer top list of best digital pharma marketers, but other brands closing in: study.” The article focuses on the findings of...
Read More
December 6, 2024

Trinity Life Sciences Releases Annual TGaS Digital Marketing Competency Report

Check out Pharmaceutical Executive’s article entitled, “Trinity Life Sciences Releases Annual TGaS Digital Marketing Competency Report” to learn more about our annual TGaS Digital Marketing Competency Report:
Read More
December 5, 2024

Pfizer’s Nurtec, AstraZeneca’s Breztri top pharma brand report

Trinity’s Jerry Luciano and Tim McLaughlin were featured in an article by MM+M titled, “Pfizer’s Nurtec, AstraZeneca’s Breztri top pharma brand report.” The article focuses on the findings of the fourth annual TGaS Digital Marketing Competency Report. Read the article to...
Read More
Back To Top